These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


865 related items for PubMed ID: 22759961

  • 1. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
    Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, Du SX.
    Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells.
    Hou GQ, Guo C, Song GH, Fang N, Fan WJ, Chen XD, Yuan L, Wang ZQ.
    Int J Mol Med; 2013 Aug; 32(2):503-10. PubMed ID: 23740407
    [Abstract] [Full Text] [Related]

  • 3. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [Abstract] [Full Text] [Related]

  • 4. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS, Ma CJ, Kim DS, Ma JY.
    J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ, Kim KN, Heo SJ, Han SC, Kim J, Ko YJ, Kang HK, Yoo ES.
    Biochem Biophys Res Commun; 2013 May 17; 434(4):892-7. PubMed ID: 23611776
    [Abstract] [Full Text] [Related]

  • 7. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
    van Heerden B, Kasonga A, Kruger MC, Coetzee M.
    Nutrients; 2017 Apr 28; 9(5):. PubMed ID: 28452958
    [Abstract] [Full Text] [Related]

  • 8. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J.
    J Bone Miner Res; 2004 Nov 28; 19(11):1905-16. PubMed ID: 15476591
    [Abstract] [Full Text] [Related]

  • 9. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM, Bhattacharya A, Fernandes G.
    J Lipid Res; 2006 Aug 28; 47(8):1739-48. PubMed ID: 16702601
    [Abstract] [Full Text] [Related]

  • 10. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS, Suh KS, Sul D, Kim BJ, Lee SK, Jung WW.
    Int J Mol Med; 2012 Feb 28; 29(2):169-77. PubMed ID: 22038020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
    Kimura K, Kitaura H, Fujii T, Hakami ZW, Takano-Yamamoto T.
    FEMS Immunol Med Microbiol; 2012 Mar 28; 64(2):219-27. PubMed ID: 22067001
    [Abstract] [Full Text] [Related]

  • 14. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F, Suzuki N, Yonehara Y, Maeno M.
    Biochimie; 2010 Apr 28; 92(4):398-404. PubMed ID: 20045440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
    Hsieh TP, Sheu SY, Sun JS, Chen MH.
    Phytomedicine; 2011 Jan 15; 18(2-3):176-85. PubMed ID: 20554188
    [Abstract] [Full Text] [Related]

  • 18. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar 15; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

  • 19. Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.
    Geng DC, Zhu XS, Mao HQ, Meng B, Chen L, Yang HL, Xu YZ.
    J Biomed Mater Res A; 2011 Dec 15; 99(4):516-22. PubMed ID: 21913318
    [Abstract] [Full Text] [Related]

  • 20. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S, Hirano S, Kayama F.
    Toxicology; 2004 Oct 15; 203(1-3):211-20. PubMed ID: 15363596
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.